Skip to Content


In the US, NovoSeven (coagulation factor viia systemic) is a member of the drug class miscellaneous coagulation modifiers and is used to treat Factor VII Deficiency, Hemophilia A and Hemophilia B.

US matches:

Ingredient matches for NovoSeven

Coagulation Factor VII, Human

Coagulation Factor VII, Human is reported as an ingredient of NovoSeven in the following countries:

  • Colombia

International Drug Name Search

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.